|
1
|
Ootani T, Shirai Y, Tsukada K and Muto T:
Relationship between gallbladder carcinoma and the segmental type
of adenomyomatosis of the gallbladder. Cancer. 69:2647–2652. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kim WS, Jang KT, Choi DW, Choi SH, Heo JS,
You DD and Lee HG: Clinicopathologic analysis of
adenosquamoussquamous cell carcinoma of the gallbladder. J Surg
Oncol. 103:239–242. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rege TA and Hagood JS: Thy-1 as a
regulator of cell-cell and cell-matrix interactions in axon
regeneration, apoptosis, adhesion, migration, cancer, and fibrosis.
FASEB J. 20:1045–1054. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
True LD, Zhang H, Ye M, Huang CY, Nelson
PS, von Haller PD, Tjoelker LW, Kim JS, Qian WJ, Smith RD, et al:
CD90THY1 is overexpressed in prostate cancer-associated fibroblasts
and could serve as a cancer biomarker. Mod Pathol. 23:1346–1356.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sukowati CH, Anfuso B, Torre G,
Francalanci P, Crocè LS and Tiribelli C: The expression of
CD90Thy-1 in hepatocellular carcinoma: An in vivo and in vitro
study. PLoS One. 8:e768302013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lingala S, Cui YY, Chen X, Ruebner BH,
Qian XF, Zern MA and Wu J: Immunohistochemical staining of cancer
stem cell markers in hepatocellular carcinoma. Exp Mol Pathol.
89:27–35. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lu JW, Chang JG, Yeh KT, Chen RM, Tsai JJ
and Hu RM: Overexpression of Thy1CD90 in human hepatocellular
carcinoma is associated with HBV infection and poor prognosis. Acta
Histochem. 113:833–838. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Johansson I, Ringnér M and Hedenfalk I:
The landscape of candidate driver genes differs between male and
female breast cancer. PLoS One. 8:e782992013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Saalbach A, Wetzel A, Haustein UF,
Sticherling M, Simon JC and Anderegg U: Interaction of human Thy-1
(CD 90) with the integrin alphavbeta3 (CD51CD61): An important
mechanism mediating melanoma cell adhesion to activated
endothelium. Oncogene. 24:4710–4720. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Abeysinghe HR, Pollock SJ, Guckert NL,
Veyberman Y, Keng P, Halterman M, Federoff HJ, Rosenblatt JP and
Wang N: The role of the THY1 gene in human ovarian cancer
suppression based on transfection studies. Cancer Genet Cytogenet.
149:1–10. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lung HL, Cheung AK, Cheng Y, Kwong FM, Lo
PH, Law EW, Chua D, Zabarovsky ER, Wang N, Tsao SW, et al:
Functional characterization of THY1 as a tumor suppressor gene with
antiinvasive activity in nasopharyngeal carcinoma. Int J Cancer.
127:304–312. 2010.PubMed/NCBI
|
|
12
|
Belkin AM and Stepp MA: Integrins as
receptors for laminins. Microsc Res Tech. 51:280–301. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lowell CA and Mayadas TN: Overview:
Studying integrins in vivo. Methods Mol Biol. 757:369–397. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Carloni V, Mazzocca A, Pantaleo P,
Cordella C, Laffi G and Gentilini P: The integrin, alpha6beta1, is
necessary for the matrix-dependent activation of FAK and MAP kinase
and the migration of human hepatocarcinoma cells. Hepatology.
34:42–49. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yoon SO, Shin S and Lipscomb EA: A novel
mechanism for integrin-mediated ras activation in breast carcinoma
cells: The alpha6beta4 integrin regulates ErbB2 translation and
transactivates epidermal growth factor receptorErbB2 signaling.
Cancer Res. 66:2732–2739. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
He J, Liu Y, Zhu T, Zhu J, Dimeco F,
Vescovi AL, Heth JA, Muraszko KM, Fan X and Lubman DM: CD90 is
identified as a candidate marker for cancer stem cells in primary
high-grade gliomas using tissue microarrays. Mol Cell Proteomics.
11:M1112012. View Article : Google Scholar
|
|
17
|
Cariati M, Naderi A, Brown JP, Smalley MJ,
Pinder SE, Caldas C and Purushotham AD: Alpha-6 integrin is
necessary for the tumourigenicity of a stem cell-like subpopulation
within the MCF7 breast cancer cell line. Int J Cancer. 122:298–304.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yamamoto H, Masters JR, Dasgupta P,
Chandra A, Popert R, Freeman A and Ahmed A: CD49f is an efficient
marker of monolayer- and spheroid colony-forming cells of the
benign and malignant human prostate. PLoS One. 7:e469792012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pascal LE, Goo YA, Vêncio RZ, Page LS,
Chambers AA, Liebeskind ES, Takayama TK, True LD and Liu AY: Gene
expression downregulation in CD90+ prostate tumor-associated
stromal cells involves potential organ-specific genes. BMC Cancer.
9:3172009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kopper L and Hajdú M: Tumor stem cells.
Pathol Oncol Res. 10:69–73. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Martin TA and Jiang WG: Evaluation of the
expression of stem cell markers in human breast cancer reveals a
correlation with clinical progression and metastatic disease in
ductal carcinoma. Oncol Rep. 31:262–272. 2014.PubMed/NCBI
|
|
22
|
Yang W, Yan HX, Chen L, Liu Q, He YQ, Yu
LX, Zhang SH, Huang DD, Tang L, Kong XN, et al: Wntbeta-catenin
signaling contributes to activation of normal and tumorigenic liver
progenitor cells. Cancer Res. 68:4287–4295. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Haraguchi N, Ishii H, Mimori K, Ohta K,
Uemura M, Nishimura J, Hata T, Takemasa I, Mizushima T, Yamamoto H,
et al: CD49f-positive cell population efficiently enriches colon
cancer-initiating cells. Int J Oncol. 43:425–430. 2013.PubMed/NCBI
|
|
24
|
Hermann PC, Huber SL, Herrler T, Aicher A,
Ellwart JW, Guba M, Bruns CJ and Heeschen C: Distinct populations
of cancer stem cells determine tumor growth and metastatic activity
in human pancreatic cancer. Cell Stem Cell. 1:313–323. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Khan SA, Davidson BR, Goldin R, Pereira
SP, Rosenberg WM, Taylor-Robinson SD, Thillainayagam AV, Thomas HC,
Thursz MR and Wasan H: British Society of Gastroenterology:
Guidelines for the diagnosis and treatment of cholangiocarcinoma:
Consensus document. Gut 51 (Suppl 6). 7–9. 2002.
|
|
26
|
Sobin LH, Gospodarowicz MK and Wittekind
C: International Union Against Cancer (UICC) TNM Classification of
Malignant Tumors. 7th. Wiley-Liss; New York, NY: 2009
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li QL, Yang ZL, Liu JQ and Miao XY:
Expression of CDX2 and hepatocyte antigen in benign and malignant
lesions of gallbladder and its correlation with histopathologic
type and clinical outcome. Pathol Oncol Res. 17:561–568. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rege TA and Hagood JS: Thy-1, a versatile
modulator of signaling affecting cellular adhesion, proliferation,
survival, and cytokinegrowth factor responses. Biochim Biophys
Acta. 1763:991–999. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Taube JH, Herschkowitz JI, Komurov K, Zhou
AY, Gupta S, Yang J, Hartwell K, Onder TT, Gupta PB, Evans KW, et
al: Core epithelial-to-mesenchymal transition interactome
gene-expression signature is associated with claudin-low and
metaplastic breast cancer subtypes. Proc Natl Acad Sci USA.
107:15449–15454. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cheng BQ, Jiang Y, Li DL, Fan JJ and Ma M:
Upregulation of thy-1 promotes invasion and metastasis of
hepatocarcinomas. Asian Pac J Cancer Prev. 13:1349–1353. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lu P, Weaver VM and Werb Z: The
extracellular matrix: A dynamic niche in cancer progression. J Cell
Biol. 196:395–406. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guo W and Giancotti FG: Integrin
signalling during tumour progression. Nat Rev Mol Cell Biol.
5:816–826. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tian B, Li Y, Ji XN, Chen J, Xue Q, Ye SL,
Liu YK and Tang ZY: Basement membrane proteins play an active role
in the invasive process of human hepatocellular carcinoma cells
with high metastasis potential. J Cancer Res Clin Oncol. 131:80–86.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ports MO, Nagle RB, Pond GD and Cress AE:
Extracellular engagement of alpha6 integrin inhibited
urokinase-type plasminogen activator-mediated cleavage and delayed
human prostate bone metastasis. Cancer Res. 69:5007–5014. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kalogeropoulou M, Voulgari A, Kostourou V,
Sandaltzopoulos R, Dikstein R, Davidson I, Tora L and Pintzas A:
TAF4b and Junactivating protein-1 collaborate to regulate the
expression of integrin alpha6 and cancer cell migration properties.
Mol Cancer Res. 8:554–568. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Germain M, De Arcangelis A, Robinson SD,
Baker M, Tavora B, D'Amico G, Silva R, Kostourou V, Reynolds LE,
Watson A, et al: Genetic ablation of the alpha 6-integrin subunit
in Tie1Cre mice enhances tumour angiogenesis. J Pathol.
220:370–381. 2010.PubMed/NCBI
|
|
38
|
Yamakawa N, Kaneda K, Saito Y, Ichihara E
and Morishita K: The increased expression of integrin alpha6
(ITGA6) enhances drug resistance in EVI1 (high) leukemia. PLoS One.
7:e307062012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Vassilopoulos A, Chisholm C, Lahusen T,
Zheng H and Deng CX: A critical role of CD29 and CD49f in mediating
metastasis for cancer-initiating cells isolated from a
Brca1-associated mouse model of breast cancer. Oncogene.
33:5477–5482. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lathia JD, Gallagher J, Heddleston JM,
Wang J, Eyler CE, Macswords J, Wu Q, Vasanji A, McLendon RE,
Hjelmeland AB and Rich JN: Integrin alpha 6 regulates glioblastoma
stem cells. Cell Stem Cell. 6:421–432. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Herrera MB, Bruno S, Buttiglieri S, Tetta
C, Gatti S, Deregibus MC, Bussolati B and Camussi G: Isolation and
characterization of a stem cell population from adult human liver.
Stem Cells. 24:2840–2850. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Dan YY, Riehle KJ, Lazaro C, Teoh N, Haque
J, Campbell JS and Fausto N: Isolation of multipotent progenitor
cells from human fetal liver capable of differentiating into liver
and mesenchymal lineages. Proc Natl Acad Sci USA. 103:9912–9917.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yang ZF, Ngai P, Ho DW, Yu WC, Ng MN, Lau
CK, Li ML, Tam KH, Lam CT, Poon RT and Fan ST: Identification of
local and circulating cancer stem cells in human liver cancer.
Hepatology. 47:919–928. 2008. View Article : Google Scholar : PubMed/NCBI
|
